Some practical considerations and applications of the national cancer institute in vitro anticancer drug discovery screen
The DOI matches its Crossref record; 39 of the 40 references it cites were found in a registry or an index, and 1 are not checked yet.
Abstract
During 1985–1990 the U.S. National Cancer Institute (NCI) phased out its murine leukemia P388 anticancer drug screening program and developed as the replacement a new in vitro primary screen based upon a diverse panel of human tumor cell lines. For each substance tested, the screen generates a remarkably reproducible and characteristic profile of differential in vitro cellular sensitivity, or lack thereof, across the 60 different cell lines comprising the panel. Several investigational approaches to display, analysis, and interpretation of such profiles and databases, derived from the testing of tens of thousands of substances during the past 4–5 years since the NCI screen became fully operational, have been explored. A variety of useful, practical applications of the in vitro screen have become apparent. As these applications continue to evolve, they are proving to be complementary to diverse other anticancer screening and drug discovery strategies being developed or pursued elsewhere. Reviewed herein are some practical considerations and selected specific examples, particularly illustrating research applications of the NCI screen that may be more broadly applicable to the search for new anticancer drug development leads with novel profiles of antitumor activity and/or mechanisms of action. © 1995 Wiley‐Liss, Inc. This article is a US Government work and, as such, is in the public domain in the United States of America.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“For example, in December 1992, MDA‐MB‐435 was added to the NCI‐60 cell line panel for use in anticancer drug screening, where it was initially described as a “breast” cancer cell line.17”
From Authentication of M14 melanoma cell line proves misidentification of MDA‐MB‐435 breast cancer cell line (2018) · cites this paper as [17]
Citations
Cites
New Colorimetric Cytotoxicity Assay for Anticancer-Drug Screening
Skehan, P., Storeng, R., Scudiero, D., Monks, A., McMahon, J., Vistica, D., Warren, J. T., Bokesch, H., Kenney, S., & Boyd, M. R. (1990) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/82.13.1107 · Cited by 9,766
Self-citationMonks, A., Scudiero, D., Skehan, P., Shoemaker, R., Paull, K., Vistica, D., Hose, C., Langley, J., Cronise, P., Vaigro-Wolff, A., et al. (1991) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/83.11.757 · Cited by 3,289
Self-citationA Human Cell Line From a Pleural Effusion Derived From a Breast Carcinoma 2
Soule, H. D., Vazquez, J., Long, A., Albert, S., & Brennan, M. (1973) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/51.5.1409 · Cited by 2,449
Establishment and characterization of a human prostatic carcinoma cell line (PC-3).
Kaighn, M. E., Ks, N., Ohnuki, Y., Lechner, J. F., & Jones, L. W. (1979) · PubMed · Cited by 2,121
Breast Tumor Cell Lines From Pleural Effusions2
Cailleau, R., Young, R., Olivé, M., & Reeves, W. J. (1974) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/53.3.661 · Cited by 1,015
Paull, K. D., Shoemaker, R. H., Hodes, L., Monks, A., Scudiero, D. A., Rubinstein, L., Plowman, J., & Boyd, M. R. (1989) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/81.14.1088 · Cited by 967
Self-citationRubinstein, L. V., Shoemaker, R. H., Paull, K. D., Simon, R. M., Tosini, S., Skehan, P., Scudiero, D. A., Monks, A., & Boyd, M. R. (1990) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/82.13.1113 · Cited by 927
Self-citationIsolation of a human prostate carcinoma cell line (DU 145)
Stone, K. R., Mickey, D. D., Wunderli, H., Mickey, G. H., & Paulson, D. F. (1978) · International Journal of Cancer · doi:10.1002/ijc.2910210305 · Cited by 926
Long-term human breast carcinoma cell lines of metastatic origin: Preliminary characterization
Cailleau, R., Olivé, M., & Cruciger, Q. V. J. (1978) · In Vitro · doi:10.1007/bf02616120 · Cited by 679
Establishment and characterization of a cell line of human breast carcinoma origin
Keydar, I., Chen, L., Karby, S., Weiss, F. R., Delarea, J., Radu, M., Chaitcik, S., & Brenner, H. J. (1979) · European Journal of Cancer (1965) · doi:10.1016/0014-2964(79)90139-7 · Cited by 650
Research works printed but not linked: 6
- Acton EM, 1992, Anticancer specificity of some ellipticinium salts against human brain tumors in vitro, Proc Am Assoc Cancer Res, 33, 488
- Boyd MR, 1986, Accomplishments in Oncology, Vol 1, Cancer Therapy: Where Do We Go From Here?, 68
- Boyd MR, 1989, Cancer: Principles and Practice of Oncology Updates, 1
- Buolamwini JK, 1994, Searching for new molecular targets for therapy of cancer and AIDS: Characterization by 2D protein gel electrophoresis, Proc Am Assoc Cancer Res, 35, 613
- Grever MR, 1994, Status of in vivo evaluations in the NCI anticancer drug discovery program, Proc Am Assoc Cancer Res, 35, 369
- Stinson SF, 1992, Morphologic and immunocytochemical characteristics of human tumor cell lines for use in an anticancer drug screen, Anticancer Res, 12, 1035
Cited by
Items 801–900 of 1,000
Wong, D. V. T., Filho, H. V. R., Wanderley, C. W. S., Leite, C. A., Lima, J. B., Assef, A. N. B., Cajado, A. G., Batista, G. D. O., González, R. H., Silva, K. O., et al. (2019) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-019-03844-z · Cited by 21
Large inherent variability in data derived from highly standardised cell culture experiments
Reddin, I. G., Fenton, T. R., Wass, M. N., & Michaelis, M. (2023) · Pharmacological Research · doi:10.1016/j.phrs.2023.106671 · Cited by 23
Salahuddin, S., Mazumder, A., & Yar, M. S. (2014) · BioMed Research International · doi:10.1155/2014/491492 · Cited by 25
Design, Synthesis, and Antitumor Evaluation of Novel Pyrazolo[3,4-d]pyrimidine Derivatives
Kandeel, M. M., Mohamed, L. W., Hamid, M. K. A. E., & Negmeldin, A. T. (2012) · Scientia Pharmaceutica · doi:10.3797/scipharm.1204-23 · Cited by 21
Paul, N. K., Jha, M., Bhullar, K. S., Rupasinghe, H. P. V., Balzarini, J. M., & Jha, A. (2014) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2014.09.090 · Cited by 21
New nitrogenous constituents from the South African marine Ascidian Pseudodistoma sp.
Rashid, M. A., Gustafson, K. R., Cartner, L. K., Pannell, L. K., & Boyd, M. R. (2001) · Tetrahedron · doi:10.1016/s0040-4020(01)00518-x · Cited by 21
Self-citationCytotoxic activity of a flavanone from the stem of Bauhinia variegata Linn
Balasubramanian, R., Murugesh, N., & Krishna, D. R. (2009) · Natural Product Research · doi:10.1080/14786410802553752 · Cited by 21
Pereira, A. V., Bester, M. J., Soundy, P., & Apostolides, Z. (2016) · Pharmaceutical Biology · doi:10.3109/13880209.2015.1129545 · Cited by 24
Mostafa, A. A.-F., Al-Rahmah, A. N., Surendrakumar, R., Manilal, A., & Idhayadhulla, A. (2016) · International Journal of Pharmacology · doi:10.3923/ijp.2016.290.303 · Cited by 23
9-Deoxopodophyllotoxin derivatives as anti-cancer agents
Subrahmanyam, D., Renuka, B., Kumar, A., Vandana, V., & Deevi, D. S. (1999) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/s0960-894x(99)00347-9 · Cited by 21
Khodair, A. I., Al-Masoudi, N. A., & Gesson, J. (2003) · Nucleosides Nucleotides & Nucleic Acids · doi:10.1081/ncn-120026407 · Cited by 21
Antisense Oligonucleotide Inhibition of Serine/Threonine Kinases
Cho‐Chung, Y. S. (1999) · Pharmacology & Therapeutics · doi:10.1016/s0163-7258(98)00043-6 · Cited by 21
Messina, M. S., Torrente, L., Pezacki, A. T., Humpel, H. I., Li, E. L., Miller, S. G., Verdejo‐Torres, O., Padilla‐Benavides, T., Brady, D. C., Killilea, D. W., et al. (2025) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2412816122 · Cited by 22
Fedeli, E., Lancelot, A., Domínguez, J. M., Serrano, J. L., Calvo, P., & Sierra, T. (2019) · Nanomaterials · doi:10.3390/nano9020161 · Cited by 20
Kazakova, O. B., Lopatina, T. V., Байкова, И. П., Zileeva, Z. R., Vakhitova, Y. V., & Suponitsky, K. Y. (2020) · Medicinal Chemistry Research · doi:10.1007/s00044-020-02577-6 · Cited by 20
Ye, Q., Putila, J. J., Raese, R. A., Dong, C., Qian, Y. R., Dowlati, A., & Guo, N. L. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22147658 · Cited by 20
Radiosensitivity Index is Not Fit to be Used for Dose Adjustments: A Pan-Cancer Analysis
Mistry, H. B. (2023) · Clinical Oncology · doi:10.1016/j.clon.2023.02.018 · Cited by 21
Yazdani, B., Sirous, H., Brogi, S., & Calderone, V. (2023) · Viruses · doi:10.3390/v15122291 · Cited by 21
Mahmoud, M. E., Ahmed, E., Ragab, H. M., El‐Telbany, R. F. A., & Hassan, R. A. (2024) · RSC Advances · doi:10.1039/d4ra04036h · Cited by 20
Rostom, S. A. F., & Bekhit, A. A. (2015) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2015.01.023 · Cited by 20
Useful four-carbon synthons en route to monastrol analogs
Abdou, A. M., Botros, S., Hassan, R. A., Kamel, M. M., Taber, D. F., & Taher, A. T. (2014) · Tetrahedron · doi:10.1016/j.tet.2014.11.022 · Cited by 20
Antimicrobial and Cytotoxic Activity of the Extracts of Khat Callus Cultures
Elhag, H., Mossa, J. S., & El‐Olemy, M. M. (1999) · Cited by 20
Ovais, S., Javed, K., Yaseen, S., Bashir, R., Rathore, P., Yaseen, R., Hameed, A. D., & Samim, M. (2013) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2013.06.050 · Cited by 20
Cyclosquaramides as Kinase Inhibitors with Anticancer Activity
Villalonga, P., de Mattos, S. F., Ramis, G., Obrador‐Hevia, A., Sampedro, Á., Rotger, C., & Costa, A. (2012) · ChemMedChem · doi:10.1002/cmdc.201200157 · Cited by 20
Mechanisms of action and structure-activity relationships of cytotoxic flavokawain derivatives
Thieury, C., Lebouvier, N., Guével, R. L., Barguil, Y., Herbette, G., Antheaume, C., Hnawia, E., Asakawa, Y., Nour, M., & Guillaudeux, T. (2017) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2017.01.049 · Cited by 20
Construction of Some Cytotoxic Agents with Aurone and Furoaurone Scaffolds
Hassan, G. S., Georgey, H. H., George, R. F., & Mohammed, E. R. (2017) · Future Medicinal Chemistry · doi:10.4155/fmc-2017-0147 · Cited by 20
Mrkus, L., Batinić, J., Bjeliš, N., & Jakas, A. (2018) · Amino Acids · doi:10.1007/s00726-018-2668-6 · Cited by 20
Synthesis of certain benzothieno[3,2-d]pyrimidine derivatives as a selective SIRT2 inhibitors
Khalil, N. A., Ahmed, E., Zaher, A. F., El‐Zoghbi, M. S., & Sobh, E. A. (2019) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2019.111926 · Cited by 20
Kryshchyshyn‐Dylevych, A., Garazd, M. M., Karkhut, A., Polovkovych, S. V., & Lesyk, R. (2020) · Synthetic Communications · doi:10.1080/00397911.2020.1786124 · Cited by 20
New 4-thiazolidinone-based molecules Les-2769 and Les-3266 as possible PPARγ modulators
Bar, M., Skóra, B., Tabęcka-Łonczyńska, A., Holota, S. M., Khyluk, D., Roman, O., Lesyk, R., & Szychowski, K. A. (2022) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2022.106075 · Cited by 20
A facile synthesis of C2-symmetric 17β-estradiol dimers
Rabouin, D., Perron, V., N’Zemba, B., Gaudreault, R. C., & Bérubé, G. (2003) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/s0960-894x(02)00987-3 · Cited by 20
Synthesis and in vitro anticancer studies of novel C-2 arylidene congeners of lantadenes
Tailor, N. K., Boon, H. L., & Sharma, M. (2013) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2013.04.009 · Cited by 20
Cytotoxic 1,4-bis(2-oxo-1-cycloalkylmethylene)benzenes and related compounds
Dimmock, J. R., Jha, A., Kumar, P., Zello, G. A., Quail, J. W., Oloo, E. O., Oucharek, J. J., Pasha, M. K., Seitz, D. P., Sharma, R. K., et al. (2002) · European Journal of Medicinal Chemistry · doi:10.1016/s0223-5234(01)01294-6 · Cited by 20
Edsall, A. B., Agoston, G. E., Treston, A. M., Plum, S. M., McClanahan, R. H., Lu, T., Song, W., & Cushman, M. (2007) · Journal of Medicinal Chemistry · doi:10.1021/jm070639e · Cited by 20
N-Hydroxyethyl-4-aza-didehydropodophyllotoxin derivatives as potential antitumor agents
Kumar, A., Kumar, V., Alegría, A. E., & Malhotra, S. V. (2011) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2011.04.013 · Cited by 20
What Do, Can and Should We Learn From Models To Evaluate Potential Anticancer Agents?
Burchill, S. A. (2006) · Future Oncology · doi:10.2217/14796694.2.2.201 · Cited by 20
Faidallah, H. M., Rostom, S. A. F., Khan, K. A., & Basaif, S. A. (2012) · Journal of Enzyme Inhibition and Medicinal Chemistry · doi:10.3109/14756366.2012.694880 · Cited by 20
Synthesis and biological evaluation of new 4-thiazolidinone derivatives
Güzel-Akdemir, Ö., & Salman, A. (2009) · Journal of Enzyme Inhibition and Medicinal Chemistry · doi:10.1080/14756360802608021 · Cited by 20
Scarbaci, K., Troiano, V., Ettari, R., Pinto, A., Micale, N., Giovanni, C. D., Cerchia, C., Schirmeister, T., Novellino, E., Lavecchia, A., et al. (2014) · ChemMedChem · doi:10.1002/cmdc.201402075 · Cited by 20
SYNTHESIS AND ANTITUMOR ACTIVITY OF NOVEL 2-THIOXO-4-THIAZOLIDINONES WITH BENZOTHIAZOLE MOIETIES
Мосула, Л. М., Zimenkovsky, B. S., Missir, A., Lesyk, R., & Davila, C. (2009) · Cited by 20
Benzothiazole carbamates and amides as antiproliferative species
Selaković, M., Mojsin, M. M., Stevanović, M. J., Opsenica, I., Srdić‐Rajić, T., & Šolaja, B. A. (2018) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2018.08.067 · Cited by 21
Estimation of biological affinity of nitrogen-containing conjugated heterocyclic pharmacophores
Kachaeva, M. V., Obernikhina, N., Velihina, Y. S., Zhuravlova, M., Prostota, Y. O., Kachkovsky, O. D., & Броварец, В. С. (2019) · Chemistry of Heterocyclic Compounds · doi:10.1007/s10593-019-02478-6 · Cited by 20
Synthesis of some new biologically active thiadiazolotriazinones–Part III
Holla, B. S., Rao, B. S., Gonsalves, R. A., Sarojini, B. K., & Shridhara, K. (2002) · Il Farmaco · doi:10.1016/s0014-827x(02)01260-0 · Cited by 20
Cephalostatin Analogues — Synthesis and Biological Activity
Fleßner, T., Jautelat, R., Scholz, U., & Winterfeldt, E. (2004) · Springer eBooks · doi:10.1007/978-3-7091-0581-8_1 · Cited by 20
Evaluating Chemical Structure Similarity as an Indicator of Cellular Growth Inhibition
Wallqvist, A., Huang, R., Thanki, N., & Covell, D. G. (2005) · Journal of Chemical Information and Modeling · doi:10.1021/ci0501544 · Cited by 20
Synthesis of Coumarin Analogues Clubbed 1,3,4-Thiadiazine or Thiazole and Their Anticancer Activity
Abdel‐Aziem, A., & Abdelhamid, A. O. (2021) · Polycyclic aromatic compounds · doi:10.1080/10406638.2021.1998152 · Cited by 19
Krstulović, L., Leventić, M., Rastija, V., Starčević, K., Jirouš, M., Janić, I., Karnaš, M., Lasić, K., Bajić, M., & Glavaš‐Obrovac, L. (2023) · Molecules · doi:10.3390/molecules28020540 · Cited by 19
Kornicka, A., Gzella, K., Garbacz, K., Jarosiewicz, M., Gdaniec, М., Fedorowicz, J., Balewski, Ł., Kokoszka, J., & Ordyszewska, A. (2023) · Pharmaceuticals · doi:10.3390/ph16070918 · Cited by 19
Zeid, M. M., El‐Badry, O. M., Elmeligie, S. E., & Hassan, R. A. (2024) · Chemistry & Biodiversity · doi:10.1002/cbdv.202400077 · Cited by 19
Naguib, B. H., Elsebaie, H. A., Nafie, M. S., Mohamady, S., Albujuq, N. R., Ayed, A. S., Nada, D., Khalil, A. F., Hefny, S. M., Tawfik, H. O., et al. (2024) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2024.107682 · Cited by 20
Берест, Г. Г., Voskoboynik, O. Y., Коваленко, С. І., Носуленко, И. С., Antypenko, L., Antypenko, O. M., Швець, В. М., & Katsev, A. M. (2012) · Scientia Pharmaceutica · doi:10.3797/scipharm.1111-15 · Cited by 19
Коваленко, С. І., Носуленко, И. С., Voskoboynik, A. Y., Berest, G. G., Antypenko, L. N., Antypenko, A. N., & Моисеевич, К. А. (2012) · Scientia Pharmaceutica · doi:10.3797/scipharm.1208-07 · Cited by 19
Hawco, C., Marchal, E., Uddin, M. I., Baker, A. E. G., Corkery, D., Dellaire, G., & Thompson, A. (2013) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2013.07.042 · Cited by 19
Maggio, B., Raffa, D., Raimondi, M. V., Cusimano, M. G., Plescia, F., Cascioferro, S., Cancemi, G., Lauricella, M., Carlisi, D., & Daidone, G. (2013) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2013.11.016 · Cited by 19
Cytotoxic saponin poliusaposide from Teucrium polium
Elmasri, W. A., Hegazy, M. F., Mechref, Y. S., & Paré, P. W. (2015) · RSC Advances · doi:10.1039/c5ra02713f · Cited by 19
Hameed, A. D., Ovais, S., Yaseen, R., Rathore, P., Samim, M., Singh, S., Sharma, K., Akhtar, M., & Javed, K. (2016) · Archiv der Pharmazie · doi:10.1002/ardp.201500336 · Cited by 19
Design and synthesis of some new tri-substituted pyrazole derivatives as anticancer agents
Fahmy, H. H., Srour, A. M., Ismail, M. A. H., Khater, M. A., Serya, R. A. T., & El‐Manawaty, M. A. (2016) · Research on Chemical Intermediates · doi:10.1007/s11164-016-2502-2 · Cited by 19
Murshid, S. S. A., Badr, J. M., Risinger, A. L., Mooberry, S. L., & Youssef, D. T. A. (2016) · Zeitschrift für Naturforschung C · doi:10.1515/znc-2015-0242 · Cited by 19
Synthesis and biological potentials of some new 1,3,4-oxadiazole analogues
Ahsan, M. J., Meena, R., Dubey, S., Khan, V., Manda, S., Jadav, S. S., Sharma, P., Geesi, M. H., Hassan, M. Z., Bakht, M. A., et al. (2017) · Medicinal Chemistry Research · doi:10.1007/s00044-017-2109-1 · Cited by 19
Convenient one-pot synthesis of resin acid Mannich bases as novel anticancer and antifungal agents
Tret’yakova, E. V., Zakirova, G. F., Salimova, E. V., Kukovinets, O. S., Одиноков, В. Н., & Parfenova, L. V. (2018) · Medicinal Chemistry Research · doi:10.1007/s00044-018-2227-4 · Cited by 19
Ahsan, M. J., Bhandari, L., Makkar, S., Singh, R., Hassan, M. Z., Geesi, M. H., Bakht, M. A., Jadav, S. S., Balaraju, T., Riadi, Y., et al. (2018) · Letters in Drug Design & Discovery · doi:10.2174/1570180816666181113110033 · Cited by 19
Synthesis and biological activity evaluation of new thiazolidinone-diclofenac hybrid molecules
Shepeta, Y., Lozynskyi, A., Sulyma, M., Nektegayev, I. A., Grellier, P., & Lesyk, R. (2020) · Phosphorus, sulfur, and silicon and the related elements · doi:10.1080/10426507.2020.1759060 · Cited by 19
Hadiyal, S., Lalpara, J., Parmar, N. D., & Joshi, H. S. (2021) · Polycyclic aromatic compounds · doi:10.1080/10406638.2021.1913425 · Cited by 19
Khalilullah, H., Agarwal, D. K., Ahsan, M. J., Jadav, S. S., Mohammed, H. A., Khan, M. A., Mohammed, S. A. A., & Khan, R. A. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23126548 · Cited by 19
Evaluation of Antiproliferative Effect of N‐(alkyladamantyl)phthalimides In vitro
Horvat, M., Uzelac, L., Marjanović, M., Cindro, N., Frankovic, O., Mlinarić‐Majerski, K., Kralj, M., & Basarić, N. (2011) · Chemical Biology & Drug Design · doi:10.1111/j.1747-0285.2011.01305.x · Cited by 19
Shchekotikhin, A. E., Glazunova, V. A., Luzikov, Y. N., Buyanov, V. N., Susova, O. Y., Shtil, A. A., & PREOBRAZHENSKAYA, M. N. (2006) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2006.03.052 · Cited by 19
Eine zweistufige Synthese von cytostatisch wirksamen Benzo[c]phenanthridin‐Derivaten
Clement, B., Weide, M., Wolschendorf, U., & Kock, I. (2004) · Angewandte Chemie · doi:10.1002/ange.200461969 · Cited by 19
El‐Gohary, N. S. (2013) · Medicinal Chemistry Research · doi:10.1007/s00044-013-0519-2 · Cited by 19
Ahmed, M., Azam, F., Rghigh, A., Gbaj, A. M., & Zetrini, A. E. (2012) · Journal of Pharmacy And Bioallied Sciences · doi:10.4103/0975-7406.92728 · Cited by 19
Lough, L., Sherman, D., Becerra‐Flores, M., Vasudevan, D., Lavinda, O., Ni, E., Wang, H., Ryoo, H. D., Tibes, R., & Cardozo, T. J. (2018) · Computational and Structural Biotechnology Journal · doi:10.1016/j.csbj.2018.09.003 · Cited by 20
New anti‐tumor agents. 3. Phenolic benzopyran lactone and amine derivatives
Jurd, L. (1997) · Journal of Heterocyclic Chemistry · doi:10.1002/jhet.5570340242 · Cited by 19
Drug design: 4-thiazolidinones applications. Part 2. Pharmacological profiles
Lesyk, R. (2020) · Journal of Medical Science · doi:10.20883/medical.e407 · Cited by 19
Synthesis and anticancer activity of aminopropoxytriterpenoids
Giniyatyllina, G. V., Smirnova, I. E., Kazakova, O. B., Yavorskaya, N. P., Голубева, И. С., Zhukova, O. S., Pugacheva, R. B., Николаевна, А. Г., & Poroikov, V. (2015) · Medicinal Chemistry Research · doi:10.1007/s00044-015-1392-y · Cited by 19
Singh, P., Mittal, A., Kaur, S., Hölzer, W., & Kumar, S. (2008) · Organic & Biomolecular Chemistry · doi:10.1039/b803608j · Cited by 19
Synthesis and study of some new N-substituted imide derivatives as potential anticancer agents
Jindal, D. P., Bedi, V., Jit, B., Karkra, N., Guleria, S., Bansal, R., Palusczak, A., & Hartmann, R. W. (2005) · Il Farmaco · doi:10.1016/j.farmac.2005.01.011 · Cited by 26
Chaaban, I., Hafez, H., AlZaim, I., Tannous, C., Ragab, H. M., Hazzaa, A. A. B., Ketat, S., Ghoneim, A. I., Katary, M. A., Abd-Alhaseeb, M. M., et al. (2021) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2021.105035 · Cited by 18
Synthesis, Biological Evaluation, and Docking Analysis of Novel Tetrahydrobenzothiophene Derivatives
Mishra, R., Kumar, N., & Sachan, N. (2022) · Letters in Drug Design & Discovery · doi:10.2174/1570180819666220117123958 · Cited by 18
Afzal, O., Yusuf, M., Ahsan, M. J., Altamimi, A. S. A., Bakht, M. A., Ali, A., & Salahuddin, S. (2022) · Plants · doi:10.3390/plants11202737 · Cited by 18
Elsayed, Z. M., Almahli, H., Nocentini, A., Ammara, A., Supuran, C. T., Eldehna, W. M., & Abou‐Seri, S. M. (2023) · Journal of Enzyme Inhibition and Medicinal Chemistry · doi:10.1080/14756366.2023.2191163 · Cited by 18
Hernández‐Urcera, J., Romero, A., Cruz, P., Vasconcelos, V. M., Figueras, A. J., Novoa, B., & Rodríguez, F. (2024) · Biology · doi:10.3390/biology13040255 · Cited by 23
1,3,5-Triazine: Recent Development in Synthesis of its Analogs and Biological Profile
Kumawat, J., Jain, S., Misra, N., Dwivedi, J., & Kishore, D. (2024) · Mini-Reviews in Medicinal Chemistry · doi:10.2174/0113895575309800240526180356 · Cited by 18
Ibrahim, H. A., Awadallah, F. M., Refaat, H. M., & Amin, K. M. (2018) · Future Medicinal Chemistry · doi:10.4155/fmc-2017-0174 · Cited by 18
Kendur, U., Chimmalagi, G. H., Patil, S. M., Gudasi, K. B., & Frampton, C. S. (2018) · Applied Organometallic Chemistry · doi:10.1002/aoc.4278 · Cited by 18
Kassab, A. E., El‐Dash, Y., & Gedawy, E. M. (2020) · Archiv der Pharmazie · doi:10.1002/ardp.201900319 · Cited by 18
Pranlukast Antagonizes CD49f and Reduces Stemness in Triple-Negative Breast Cancer Cells
Velázquez-Quesada, I., Ruiz-Moreno, A. J., Casique‐Aguirre, D., Aguirre-Alvarado, C., Cortés-Mendoza, F., Fuente, M. D. L., García-Pérez, C. A., Pérez‐Tapia, S. M., González‐Arenas, A., Segura‐Cabrera, A., et al. (2020) · Drug Design Development and Therapy · doi:10.2147/dddt.s247730 · Cited by 19
Radwan, M. O., Ciftci, H. I., Ali, T. F. S., Koga, R., Tateishi, H., Nakata, A., Ito, A., Yoshida, M., Fujita, M., & Otsuka, M. (2020) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2020.127458 · Cited by 18
Rasal, N. K., Sonawane, R., & Jagtap, S. V. (2021) · Chemistry & Biodiversity · doi:10.1002/cbdv.202100504 · Cited by 18
Yılmaz, A. M., Jannuzzi, A. T., Bayrak, N., Yıldız, M., Yıldırım, H., Otsuka, M., Fujita, M., Radwan, M. O., & Tuyun, A. F. (2022) · ACS Omega · doi:10.1021/acsomega.2c03428 · Cited by 18
The Role of Hydrogen Sulfide in the Development and Progression of Lung Cancer
Yang, Y., Zhang, K., Zhou, Z.-T., Jiang, Z.-L., Liu, Y., Zhang, Y., Liu, Z., Ji, X., & Wu, D. (2022) · Molecules · doi:10.3390/molecules27249005 · Cited by 18
Synthesis and antitumor activity of aminopropoxy derivatives of betulin, erythrodiol, and uvaol
Kazakova, O. B., Giniyatullina, G. V., Толстиков, Г. А., Байкова, И. П., Zaprutko, L., & Николаевна, А. Г. (2011) · Russian Journal of Bioorganic Chemistry · doi:10.1134/s1068162011030101 · Cited by 18
Pérez‐Faginas, P., Aranda, M. T., López, M. G., Francesch, A., Cuevas, C., & González‐Muñiz, R. (2011) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2011.08.025 · Cited by 18
Synthesis and anti-inflammatory activity of celecoxib like compounds
Ovais, S., Yaseen, S., Bashir, R., Rathore, P., Samim, M., Singh, S., Nair, V., & Javed, K. (2012) · Journal of Enzyme Inhibition and Medicinal Chemistry · doi:10.3109/14756366.2012.710847 · Cited by 18
Didemnaketals F and G, New Bioactive Spiroketals from a Red Sea Ascidian Didemnum Species
Shaala, L. A., Youssef, D. T. A., Ibrahim, S. R. M., Mohamed, G. A., Badr, J. M., Risinger, A. L., & Mooberry, S. L. (2014) · Marine Drugs · doi:10.3390/md12095021 · Cited by 18
Beus, M., Rajić, Z., Maysinger, D., Mlinarić, Z., Antunović, M., Marijanović, I., Fontinha, D., Prudêncio, M., Held, J., Ölgen, S., et al. (2018) · ChemistryOpen · doi:10.1002/open.201800117 · Cited by 20
Hybrid anticancer 1,2-diazine derivatives with multiple mechanism of action. Part 3 [4,5]
Antoci, V., Amăriucăi-Mantu, D., Cozma, D. G., Usru, C., & Mangalagiu, I. I. (2013) · Medical Hypotheses · doi:10.1016/j.mehy.2013.10.024 · Cited by 18
Synthesis and antimitotic activity of novel 2-methoxyestradiol analogs—Part II
Rao, P. N., Cessac, J. W., Boyd, J. W., Hanson, A. D., & Shah, J. H. (2007) · Steroids · doi:10.1016/j.steroids.2007.11.003 · Cited by 18
Sansalvamide induces pancreatic cancer growth arrest through changes in the cell cycle.
Heiferman, M. J., Salabat, M. R., Ujiki, M. B., Strouch, M. J., Cheon, E. C., Silverman, R. B., & Bentrem, D. J. (2010) · PubMed · Cited by 18
Prospecting for potentially new pharmaceuticals from natural sources
Pandey, R. C. (1998) · Medicinal Research Reviews · doi:10.1002/(sici)1098-1128(199809)18:5<333::aid-med4>3.0.co;2-u · Cited by 18
N-Acyloxy-N-alkoxyamides – structure, properties, reactivity and biological activity
Glover, S. A. (2007) · Advances in physical organic chemistry · doi:10.1016/s0065-3160(07)42002-0 · Cited by 18
Inhibition of Protein Phosphatase-1 by Clavosines A and B
McCready, T., Islam, B., Schmitz, F. J., Luu, H. A., Dawson, J., & Holmes, C. F. B. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.6.4192 · Cited by 18
Metadata
- Authors
- Boyd, M. R., & Paull, K. D.
- Affiliations
- Frederick National Laboratory for Cancer Research (US)
- National Cancer Institute (US)
- Corresponding author
- Boyd, Michael R.
- ORCID
- Boyd, Michael R.
- Venue
- Drug Development Research
- Publisher
- Wiley
- Published
- 1995-02
- Volume
- 34
- Issue
- 2
- Pages
- 91-109
- ISSN
- 0272-4391 (ISSN-L)
- 1098-2299
- OpenAlex
- W2118909720
- Cited by
- 1,572
- References
- 40
- Citations by year
- 2026: 28 · 2025: 57 · 2024: 79 · 2023: 58 · 2022: 68 · 2021: 81 · 2020: 74 · 2019: 51 · 2018: 58 · 2017: 39 · 2016: 56 · 2015: 61 · 2014: 78 · 2013: 84 · 2012: 79
- FWCI
- 30.59
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Drug Development Research (publishedVersion, public-domain)
- Topics
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Drug Discovery › Computational Drug Discovery Methods
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Cancer therapeutics and mechanisms
- Health Sciences › Medicine › Oncology › Cancer Cells and Metastasis
- Keywords
- anticancer drug discovery, human cancer cell lines, anticancer activity, lead compound identification, mechanism of action
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.